Debate erupts over off-label COVID-19 vaccine use for children under the age of five

After the federal Food and Drug Administration (FDA) delayed authorization of the Pfizer-BioNTech COVID-19 vaccine last week for children under the age of five in the United States, parents are making a passionate plea for its off-label use.

Related Keywords

Germany ,New York ,United States ,American ,Janet Woodcock ,Sean Oleary ,Fatima Khan ,Lee Savio Beers ,American Academy Of Pediatrics ,Pfizer ,New York Times ,Drug Evaluation Research ,Drug Administration ,Fox News ,American Academy ,Seano Leary ,Von Meissner ,Drug Evaluation ,